Articles

Greece To Ramp Up Tourism Strategies To Drive Increased Arrivals

Tourism / Europe / Fri 03 May, 2024

Key View: Over 2024, we expect an increase in the total tourist arrivals to Greece, with growth building on a full recovery to pre-Covid (2019) levels in 2023. Over the medium term (2024-2028), we forecast arrivals to continue expanding in line with increased arrivals from traditional and emerging major source markets for arrivals. Tourism

Read More

Pace Of Czech Policy Easing To Slow On Stronger Growth

Country Risk / Czech Republic / Fri 03 May, 2024

Key View

  • The Czech National Bank (CNB) cut rates by 50bps to 5.25% on May 2 2024, as we had expected, while adopting a less dovish tone. This has prompted us to keep our end-2024 policy rate forecast unchanged at 4.25%.
  • A firmer recovery in economic activity in 2024, which will drive higher inflationary pressure from H224, underpins our more-hawkish
Read More

Deepwater Exploration In Malaysia Gathers Momentum

Oil & Gas / Malaysia / Fri 03 May, 2024

Key View

  • Malaysia's deepwater explorations are expected to accelerate as more investments are directed towards underexplored areas.
  • International oil companies (IOCs) will continue to be crucial for Malaysia's deepwater success.
  • Malaysia could experience a significant increase in exploration expenditures in 2024 as IOCs prepare
Read More

Spanish Growth To Remain Robust In 2024 As Consumption Picks Up

Country Risk / Spain / Wed 01 May, 2024

Key View

  • We have revised up our 2024 GDP forecast for the Spanish economy as private consumption is likely to perform somewhat better than we had anticipated in 2024 and our outlook on Spain’s industry has improved. We now expect the Spanish economy to expand by 2.2% in 2024 (previously 1.5%) after 2.5% growth in 2023.
  • We remain of the view that
Read More

India’s New CAR-T Product Is A First For Emerging Markets, But Barriers Remain For India In Becoming A Cancer Innovation Hub

Pharmaceuticals / India / Wed 01 May, 2024

Key View

  • Access to cell therapies will improve across emerging markets following the approval and market launch of the first India-produced CAR-T cell therapy.
  • Aging populations and low health expenditure will continue to drive demand for lower-cost cancer therapies.
  • Growing demand for cancer care in India will put pressure on the government to grow
Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.